{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T16:20:04Z","timestamp":1785601204203,"version":"3.56.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T00:00:00Z","timestamp":1585267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s13760-020-01337-y","type":"journal-article","created":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T12:02:58Z","timestamp":1585310578000},"page":"1123-1130","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Amyotrophic lateral sclerosis with coexisting cancer: a single-center study"],"prefix":"10.1007","volume":"121","author":[{"given":"Onur","family":"Akan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Baysal-Kirac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,27]]},"reference":[{"key":"1337_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1080\/21678421.2019.1612435","volume":"20","author":"J Raymond","year":"2019","unstructured":"Raymond J, Oskarsson B, Mehta P, Horton K (2019) Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010\u20132015. Amyotroph Lateral Scler Frontotemporal Degener 20:413\u2013420","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1337_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/archneurol.2009.341","volume":"67","author":"B Giometto","year":"2010","unstructured":"Giometto B, Grisold W, Vitaliani R, Graus F, Honnorat J, Bertolini G, Euronetwork PNS (2010) Paraneoplastic neurologic syndrome in the PNS Euronetwork database: a European study from 20 centers. Arch Neurol 67:330\u2013335","journal-title":"Arch Neurol"},{"key":"1337_CR3","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1212\/WNL.0000000000002757","volume":"87","author":"SB Gibson","year":"2016","unstructured":"Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP et al (2016) Population-based risks for cancer in patients with ALS. Neurology 87:289\u2013294","journal-title":"Neurology"},{"key":"1337_CR4","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/ana.410410608","volume":"41","author":"PA Forsyth","year":"1997","unstructured":"Forsyth PA, Dalmau J, Graus F, Cwik V, Rosenblum MK, Posner JB (1997) Motor neuron syndromes in cancer patients. Ann Neurol 41:722\u2013730","journal-title":"Ann Neurol"},{"key":"1337_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/17482960701419505","volume":"8","author":"E Sadot","year":"2007","unstructured":"Sadot E, Carluer L, Corcia P, Delozier Y, Levy C, Viader F (2007) Breast cancer and motor neuron disease: clinical study of seven cases. Amyotroph Lateral Scler 8:288\u2013291","journal-title":"Amyotroph Lateral Scler"},{"key":"1337_CR6","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1111\/ene.12295","volume":"21","author":"R Spataro","year":"2014","unstructured":"Spataro R, La Bella V (2014) Paraneoplastic motor neuron disease associated with breast cancer. Eur J Neurol 21:e5\u20136","journal-title":"Eur J Neurol"},{"key":"1337_CR7","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1007\/s00415-018-8881-0","volume":"265","author":"N M\u00e9l\u00e9","year":"2018","unstructured":"M\u00e9l\u00e9 N, Berzero G, Maisonobe T, Salachas F, Nicolas G, Weiss N et al (2018) Motor neuron disease of paraneoplastic origin: a rare but treatable condition. J Neurol 265:1590\u20131599","journal-title":"J Neurol"},{"key":"1337_CR8","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/mus.23464","volume":"46","author":"EP Flanagan","year":"2012","unstructured":"Flanagan EP, Sandroni P, Pittock SJ, Inwards DJ, Jones LK Jr (2012) Paraneoplastic lower motor neuronopathy associated with Hodgkin lymphoma. Muscle Nerv 46:823\u2013827","journal-title":"Muscle Nerv"},{"key":"1337_CR9","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.jns.2015.08.014","volume":"358","author":"A Verschueren","year":"2015","unstructured":"Verschueren A, Gallard J, Boucraut J, Honnorat J, Pouget J, Attarian S (2015) Paraneoplastic subacute lower motor neuron syndrome associated with solid cancer. J Neurol Sci 358:413\u2013416","journal-title":"J Neurol Sci"},{"key":"1337_CR10","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293\u2013299","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"1337_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1212\/01.wnl.0000345041.83406.a2","volume":"72","author":"LC Wijesekera","year":"2009","unstructured":"Wijesekera LC, Mathers S, Talman P, Galtrey C, Parkinson MH, Ganesalingam J et al (2009) Natural history and clinical features of the flail arm and flail leg ALS variants. Neurology 72:1087\u20131094","journal-title":"Neurology"},{"key":"1337_CR12","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/j.1468-1331.2011.03616.x","volume":"19","author":"GM Gargiulo-Monachelli","year":"2012","unstructured":"Gargiulo-Monachelli GM, Janota F, Bettini M, Shoesmith CL, Strong MJ, Sica RE (2012) Regional spread pattern predicts survival in patients with sporadic amyotrophic lateral sclerosis. Eur J Neurol 19:834\u2013841","journal-title":"Eur J Neurol"},{"key":"1337_CR13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clinph.2007.09.143","volume":"119","author":"M de Carvalho","year":"2008","unstructured":"de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J (2008) Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol 119:497\u2013503","journal-title":"Clin Neurophysiol"},{"key":"1337_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0022-510X(99)00210-5","volume":"169","author":"JM Cedarbaum","year":"1999","unstructured":"Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B (1999) The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group [Phase III]. J Neurol Sci 169:13\u201321","journal-title":"J Neurol Sci"},{"key":"1337_CR15","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00415-013-6881-7","volume":"260","author":"A Abraham","year":"2013","unstructured":"Abraham A, Drory VE (2013) Postradiation lower motor neuron syndrome: case series and literature review. J Neurol 260:1802\u20131806","journal-title":"J Neurol"},{"key":"1337_CR16","first-page":"70","volume":"34","author":"FG Yildiz","year":"2017","unstructured":"Yildiz FG, Bekircan-Kurt CE, Varli K (2017) Single-pulse transcranial magnetic stimulation in amyotrophic lateral sclerosis: experience of a single institution. Neurol Sci Neurophysiol 34:70\u201375","journal-title":"Neurol Sci Neurophysiol"},{"key":"1337_CR17","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s004150070092","volume":"247","author":"MC Vigliani","year":"2000","unstructured":"Vigliani MC, Polo P, Chi\u00f2 A, Giometto B, Mazzini L, Schiffer D (2000) Patients with amyotrophic lateral sclerosis and cancer do not differ clinically from patients with sporadic amyotrophic lateral sclerosis. J Neurology 247:778\u2013782","journal-title":"J Neurology"},{"key":"1337_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/CND.0000000000000080","volume":"17","author":"N Al-Bustani","year":"2015","unstructured":"Al-Bustani N, Simonson W, Marshall DA, Vetrovs J, Wener MH, Weiss MD et al (2015) Utility of paraneoplastic antibody testing in the diagnosis of motor neuron disease. J Clin Neuromuscul Dis 17:63\u201368","journal-title":"J Clin Neuromuscul Dis"},{"key":"1337_CR19","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1136\/jnnp.2006.097774","volume":"78","author":"O Stich","year":"2007","unstructured":"Stich O, Kleer B, Rauer S (2007) Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease. J Neuro Neurosurg Psychiatry 78:883\u2013885","journal-title":"J Neuro Neurosurg Psychiatry"},{"key":"1337_CR20","doi-asserted-by":"crossref","unstructured":"EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis; Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, et al (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis [MALS]\u2014revised report of an EFNS task force. Eur J Neurol 19:360\u2013375","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"1337_CR21","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3109\/21678421.2014.965178","volume":"16","author":"P Corcia","year":"2015","unstructured":"Corcia P, Gordon PH, Camdessanche JP (2015) Is there a paraneoplastic ALS? Amyotroph Lateral Scler Frontotemporal Degener 16:252\u2013257","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"1337_CR22","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3109\/21678421.2013.775309","volume":"14","author":"F Fang","year":"2013","unstructured":"Fang F, Al-Chalabi A, Ronnevi LO, Turner MR, Wirdefeldt K, Kamel F, Ye W (2013) Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden. Amyotroph Lateral Sclerosis Frontotemporal Degener 14:362\u2013368","journal-title":"Amyotroph Lateral Sclerosis Frontotemporal Degener"},{"key":"1337_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s10552-012-0089-5","volume":"24","author":"DM Freedman","year":"2013","unstructured":"Freedman DM, Curtis RE, Daugherty SE, Goedert JJ, Kuncl RW, Tucker MA (2013) The association between cancer and amyotrophic lateral sclerosis. Cancer Causes Control 24:55\u201360","journal-title":"Cancer Causes Control"},{"key":"1337_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/ana.410400118","volume":"40","author":"A Verma","year":"1996","unstructured":"Verma A, Berger JR, Snodgrass S, Petito C (1996) Motor neuron disease: a paraneoplastic process associated with anti-hu antibody and small-cell lung carcinoma. Ann Neurol 40:112\u2013116","journal-title":"Ann Neurol"},{"key":"1337_CR25","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1212\/WNL.48.6.1671","volume":"48","author":"PH Gordon","year":"1997","unstructured":"Gordon PH, Rowland LP, Younger DS, Sherman WH, Hays AP, Louis ED (1997) Lymphoproliferative disorders and motor neuron disease: an update. Neurology 48:1671\u20131678","journal-title":"Neurology"},{"key":"1337_CR26","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1378\/chest.115.3.899","volume":"115","author":"D Forman","year":"1999","unstructured":"Forman D, Rae-Grant AD, Matchett SC, Cowen JS (1999) A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma. Chest 115:899\u2013901","journal-title":"Chest"},{"key":"1337_CR27","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/CND.0b013e3181c50528","volume":"12","author":"BJ Distad","year":"2010","unstructured":"Distad BJ, Weiss MD (2010) Paraneoplastic motor neuron disease associated with Purkinje cell autoantibody type 1. J Clin Neuromuscul Dis 12:36\u201341","journal-title":"J Clin Neuromuscul Dis"},{"key":"1337_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.clineuro.2018.06.038","volume":"172","author":"L Diamanti","year":"2018","unstructured":"Diamanti L, Quaquarini E, Berzero G, Bini P, Gastaldi M, Franciotta D et al (2018) Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: a case report and review of the literature. Clin Neurol Neurosurg 172:141\u2013142","journal-title":"Clin Neurol Neurosurg"},{"key":"1337_CR29","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/WCO.0000000000000475","volume":"30","author":"JC Antoine","year":"2017","unstructured":"Antoine JC, Camdessanch\u00e9 JP (2017) Paraneoplastic neuropathies. Curr Opin Neurol 30:513\u2013520","journal-title":"Curr Opin Neurol"},{"key":"1337_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.neurol.2014.07.002","volume":"170","author":"JC Antoine","year":"2014","unstructured":"Antoine JC (2014) Peripheral neuropathies associated with antibodies directed to intracellular neural antigens. Rev Neurol [Paris] 170:570\u2013576","journal-title":"Rev Neurol [Paris]"},{"key":"1337_CR31","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jnnp.60.4.388","volume":"60","author":"M Uchuya","year":"1996","unstructured":"Uchuya M, Graus F, Vega F, Re\u00f1\u00e9 R, Delattre JY (1996) Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 60:388\u2013392","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1337_CR32","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/(SICI)1097-4598(199712)20:12<1576::AID-MUS13>3.0.CO;2-Z","volume":"20","author":"SJ Oh","year":"1997","unstructured":"Oh SJ, Dropcho EJ, Claussen GC (1997) Anti-Hu-associated paraneoplastic sensory neuropathy responding to early aggressive immunotherapy: report of two cases and review of literature. Muscle Nerve 20:1576\u20131582","journal-title":"Muscle Nerve"},{"key":"1337_CR33","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1136\/jnnp.68.4.479","volume":"68","author":"F Keime-Guibert","year":"2000","unstructured":"Keime-Guibert F, Graus F, Fleury A, Ren\u00e9 R, Honnorat J, Broet P et al (2000) Treatment of paraneoplastic neurological syndromes with antineuronal antibodies [anti-Hu, anti-Yo] with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 68:479\u2013482","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1337_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s00415-005-0882-0","volume":"253","author":"S Shams'ili","year":"2006","unstructured":"Shams'ili S, de Beukelaar J, Gratama JW, Hooijkaas H, van den Bent M, van't Veer M et al (2006) An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol 253:16\u201320","journal-title":"J Neurol"},{"key":"1337_CR35","first-page":"CD007625","volume":"12","author":"B Giometto","year":"2012","unstructured":"Giometto B, Vitaliani R, Lindeck-Pozza E, Grisold W, Vedeler C (2012) Treatment for paraneoplastic neuropathies. Cochrane Database Syst Rev 12:CD007625","journal-title":"Cochrane Database Syst Rev"},{"key":"1337_CR36","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"400","key":"1337_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jns.2019.03.024","volume":"15","author":"M Cheli","year":"2019","unstructured":"Cheli M, Dinoto A, Ridolfi M, Sartori A, Stokelj D, Manganotti P (2019) Motor neuron disease as a treatment responsive paraneoplastic neurological syndrome in patient with small cell lung cancer, anti-Hu antibodies and limbic encephalitis. J Neurol Sci 15(400):158\u2013159","journal-title":"J Neurol Sci"},{"key":"1337_CR38","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10072-019-03784-9","volume":"40","author":"J Goodfellow","year":"2019","unstructured":"Goodfellow J, Gorrie G, Leach V, Patel S, Mackay G (2019) Cancer and motor neuron disease-causal or coincidental? Two contrasting cases. Neurol Sci 40:1461\u20131463","journal-title":"Neurol Sci"},{"key":"1337_CR39","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/CND.0000000000000056","volume":"16","author":"AF Struck","year":"2014","unstructured":"Struck AF, Salamat S, Waclawik AJ (2014) Motor neuron disease with selective degeneration of anterior horn cells associated with non-Hodgkin lymphoma. J Clin Neuromuscul Dis 16:83\u201389","journal-title":"J Clin Neuromuscul Dis"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-020-01337-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-020-01337-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T12:40:10Z","timestamp":1631709610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-020-01337-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,27]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["1337"],"URL":"https:\/\/doi.org\/10.1007\/s13760-020-01337-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,27]]},"assertion":[{"value":"17 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}